Skip Navigation



European Heart Journal Advance Access published online on December 15, 2004

European Heart Journal, doi:10.1093/eurheartj/ehi070
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
26/5/498    most recent
ehi070v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Glorioso, N.
Right arrow Articles by Mulatero, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glorioso, N.
Right arrow Articles by Mulatero, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

European Heart Journal © The European Society of Cardiology 2004; all rights reserved

Clinical research

11{beta}-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension

Nicola Glorioso 1*, Fabiana Filigheddu 1, Paolo Pinna Parpaglia 2, Aldo Soro 1, Chiara Troffa 1, Giuseppe Argiolas 1, and Paolo Mulatero 3

1 Hypertension and Cardiovascular Prevention Centre, ASL n.1-University of Sassari, Italy
2 Emergency Department, ASL n.1, Sassari, Italy
3 Hypertension Centre, University of Torino, Italy

* To whom correspondence should be addressed.
Nicola Glorioso, E-mail: glorioso{at}uniss.it


   Abstract

Aims Left ventricular mass (LVM) is under the control of aldosterone and angiotensin II in experimental hypertension, but the effect of aldosterone on LVM is controversial in essential hypertension (EH). Some EH patients show a mild impairment of 11{beta}-hydroxysteroid dehydrogenase type 2 (11{beta}-HSD2) activity without clinical features of the syndrome of apparent mineralocorticoid excess, where the incomplete cortisol-to-cortisone conversion leads to glucocorticoid-mediated mineralocorticoid effects. The mineralocorticoid receptor and 11{beta}-HSD2 are co-expressed in human heart. We investigated whether LVM may be regulated by glucocorticoids in EH patients.

Methods and results The ratio between 24h urinary tetrahydro derivatives of cortisol and cortisone (THFs/THE), plasma renin activity, 24 h urinary aldosterone, blood pressure, and LVM indexed for height2.7 (LVMh2.7) were analysed in 493 never-treated hypertensives and 98 normotensives. THFs/THE was associated with LVMh2.7 in hypertensives and normotensives (r = 0.32, P < 0.001, and r = 0.17, P = 0.04, respectively) and persisted after adjusting for confounders (multiple regression analysis). Body mass index, sex, recumbent plasma renin activity, and THFs/THE accounted for 26.1% of LVMh2.7 variation. Urinary aldosterone was not correlated with LVMh2.7.

Conclusion We suggest that glucocorticoids may take part in the regulation of LVM in EH patients as a function of 11{beta}-HSD2 activity, and contribute to the target organ damage associated with essential hypertension.

Keywords: Cardiac mass; 11{beta}-Hydroxysteroid dehydrogenase; Mineralocorticoids; Glucocorticoids; Blood pressure.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Wenxia Chai, Y. M Hoedemaekers, R. H. van Schaik, M. van Fessem, I. M Garrelds, J. J Saris, D. Dooijes, F. J ten Cate, M. M. Kofflard, and A. J. Danser
Cardiac aldosterone in subjects with hypertrophic cardiomyopathy
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 225 - 230.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. Reini, C. E. Wood, E. Jensen, and M. Keller-Wood
Increased maternal cortisol in late-gestation ewes decreases fetal cardiac expression of 11beta-HSD2 mRNA and the ratio of AT1 to AT2 receptor mRNA
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1708 - R1716.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.